# OnCo record bria-imt (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bria-imt/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bria-imt" ;
  schema:name "Bria-IMT"@en ;
  schema:description "Bria-IMT is an off-the-shelf immunotherapy made from laboratory-grown cancer cells, from BriaCell Therapeutics. It is being tested with a checkpoint inhibitor in a phase 3 trial in metastatic breast cancer."@en ;
  schema:url <https://onco.cc/drugs/bria-imt/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://briacell.com/>, <https://clinicaltrials.gov/study/NCT06072612> ;
  onco:status "phase-3" ;
  onco:tag "pipeline" ;
  onco:modality "Off-the-shelf cell-based immunotherapy" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:companies <https://onco.cc/companies/briacell/> ;
  onco:trials <https://onco.cc/trials/nct06072612/> .
